Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

SciClone Pharmaceuticals Inc (NASDAQ:SCLN)

10.90
Delayed Data
As of Jun 27
 -0.05 / -0.46%
Today’s Change
8.55
Today|||52-Week Range
13.73
+0.93%
Year-to-Date
No recent news for SciClone Pharmaceuticals Inc.

Today’s Trading

Previous close10.95
Today’s open10.95
Day’s range10.90 - 10.95
Volume269,289
Average volume (3 months)470,245
Market cap$566.5M
Dividend yield--
Data as of 06/27/2017

Growth & Valuation

Earnings growth (last year)+3.57%
Earnings growth (this year)+62.07%
Earnings growth (next 5 years)+14.70%
Revenue growth (last year)+1.81%
P/E ratio15.4
Price/Sales3.55
Price/Book2.61

Competitors

 Today’s
change
Today’s
% change
OTICOtonomy Inc-0.50-2.64%
ITCIIntra-Cellular Thera...-0.33-2.58%
CTMXCytomX Therapeutics ...-0.45-3.02%
ACHNAchillion Pharmaceut...+0.02+0.45%
Data as of 06/27/2017

Financials

Next reporting dateAugust 9, 2017
EPS forecast (this quarter)$0.24
Annual revenue (last year)$160.1M
Annual profit (last year)$30.7M
Net profit margin19.19%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Friedhelm Blobel
Chief Financial Officer &
Senior VP-Finance
Wai-Shun Cheung
Corporate headquarters
Foster City, California

Forecasts